Rankings
▼
Calendar
IOVA Q3 2016 Earnings — Iovance Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena
IOVA
Iovance Biotherapeutics, Inc.
$2B
Q3 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$19M
Net Income
-$19M
EPS (Diluted)
$-1.15
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$12M
Free Cash Flow
-$13M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$182M
Total Liabilities
$3M
Stockholders' Equity
$179M
Cash & Equivalents
$93M
← FY 2016
All Quarters
Q4 2016 →
